Logo image of TRNS

TRANSCAT INC (TRNS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TRNS - US8935291075 - Common Stock

63.24 USD
+3.03 (+5.03%)
Last: 1/8/2026, 8:11:09 PM
63.24 USD
0 (0%)
After Hours: 1/8/2026, 8:11:09 PM
Fundamental Rating

5

Taking everything into account, TRNS scores 5 out of 10 in our fundamental rating. TRNS was compared to 50 industry peers in the Trading Companies & Distributors industry. TRNS has an average financial health and profitability rating. TRNS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

TRNS had positive earnings in the past year.
TRNS had a positive operating cash flow in the past year.
In the past 5 years TRNS has always been profitable.
TRNS had a positive operating cash flow in each of the past 5 years.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

TRNS has a Return On Assets (2.34%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 3.84%, TRNS is doing worse than 62.00% of the companies in the same industry.
TRNS has a Return On Invested Capital of 3.29%. This is in the lower half of the industry: TRNS underperforms 64.00% of its industry peers.
TRNS had an Average Return On Invested Capital over the past 3 years of 6.00%. This is below the industry average of 9.63%.
Industry RankSector Rank
ROA 2.34%
ROE 3.84%
ROIC 3.29%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

TRNS has a Profit Margin (3.75%) which is comparable to the rest of the industry.
TRNS's Profit Margin has improved in the last couple of years.
TRNS has a Operating Margin (6.39%) which is comparable to the rest of the industry.
TRNS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 32.45%, TRNS is in line with its industry, outperforming 60.00% of the companies in the same industry.
TRNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.39%
PM (TTM) 3.75%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TRNS is destroying value.
The number of shares outstanding for TRNS has been increased compared to 1 year ago.
TRNS has more shares outstanding than it did 5 years ago.
TRNS has a worse debt/assets ratio than last year.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

TRNS has an Altman-Z score of 2.94. This is not the best score and indicates that TRNS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.94, TRNS is in line with its industry, outperforming 48.00% of the companies in the same industry.
TRNS has a debt to FCF ratio of 4.45. This is a neutral value as TRNS would need 4.45 years to pay back of all of its debts.
The Debt to FCF ratio of TRNS (4.45) is better than 62.00% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that TRNS is not too dependend on debt financing.
TRNS has a Debt to Equity ratio (0.38) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.45
Altman-Z 2.94
ROIC/WACC0.34
WACC9.72%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

TRNS has a Current Ratio of 2.43. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
TRNS has a better Current ratio (2.43) than 64.00% of its industry peers.
TRNS has a Quick Ratio of 2.06. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
TRNS's Quick ratio of 2.06 is fine compared to the rest of the industry. TRNS outperforms 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.06
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

TRNS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.66%.
The Earnings Per Share has been growing slightly by 6.36% on average over the past years.
The Revenue has grown by 11.81% in the past year. This is quite good.
TRNS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.97% yearly.
EPS 1Y (TTM)-15.66%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%25.71%
Revenue 1Y (TTM)11.81%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%21.3%

3.2 Future

The Earnings Per Share is expected to grow by 19.42% on average over the next years. This is quite good.
Based on estimates for the next years, TRNS will show a quite strong growth in Revenue. The Revenue will grow by 9.30% on average per year.
EPS Next Y47.1%
EPS Next 2Y31.71%
EPS Next 3Y16.78%
EPS Next 5Y19.42%
Revenue Next Year18.13%
Revenue Next 2Y12.77%
Revenue Next 3Y9.23%
Revenue Next 5Y9.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 37.87, which means the current valuation is very expensive for TRNS.
TRNS's Price/Earnings ratio is a bit more expensive when compared to the industry. TRNS is more expensive than 60.00% of the companies in the same industry.
TRNS's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.00.
A Price/Forward Earnings ratio of 24.80 indicates a rather expensive valuation of TRNS.
TRNS's Price/Forward Earnings ratio is in line with the industry average.
TRNS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.70.
Industry RankSector Rank
PE 37.87
Fwd PE 24.8
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TRNS is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, TRNS is valued a bit cheaper than 72.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.47
EV/EBITDA 16.12
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TRNS's earnings are expected to grow with 16.78% in the coming years.
PEG (NY)0.8
PEG (5Y)5.95
EPS Next 2Y31.71%
EPS Next 3Y16.78%

0

5. Dividend

5.1 Amount

No dividends for TRNS!.
Industry RankSector Rank
Dividend Yield 0%

TRANSCAT INC

NASDAQ:TRNS (1/8/2026, 8:11:09 PM)

After market: 63.24 0 (0%)

63.24

+3.03 (+5.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)01-26 2026-01-26
Inst Owners98.89%
Inst Owner Change0%
Ins Owners0.99%
Ins Owner Change1.01%
Market Cap590.03M
Revenue(TTM)302.58M
Net Income(TTM)11.35M
Analysts80
Price Target105.74 (67.2%)
Short Float %4.47%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.93%
Min EPS beat(2)-14.58%
Max EPS beat(2)46.44%
EPS beat(4)2
Avg EPS beat(4)2.63%
Min EPS beat(4)-24%
Max EPS beat(4)46.44%
EPS beat(8)5
Avg EPS beat(8)8.39%
EPS beat(12)7
Avg EPS beat(12)3.58%
EPS beat(16)8
Avg EPS beat(16)2.32%
Revenue beat(2)2
Avg Revenue beat(2)2.55%
Min Revenue beat(2)1.44%
Max Revenue beat(2)3.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-6.92%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)5
Avg Revenue beat(12)-1.13%
Revenue beat(16)7
Avg Revenue beat(16)-0.89%
PT rev (1m)-5.97%
PT rev (3m)-5.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.09%
Revenue NQ rev (1m)-0.97%
Revenue NQ rev (3m)3.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.44%
Valuation
Industry RankSector Rank
PE 37.87
Fwd PE 24.8
P/S 1.95
P/FCF 23.47
P/OCF 14.85
P/B 2
P/tB N/A
EV/EBITDA 16.12
EPS(TTM)1.67
EY2.64%
EPS(NY)2.55
Fwd EY4.03%
FCF(TTM)2.69
FCFY4.26%
OCF(TTM)4.26
OCFY6.73%
SpS32.43
BVpS31.66
TBVpS-0.87
PEG (NY)0.8
PEG (5Y)5.95
Graham Number34.49
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.84%
ROCE 4.3%
ROIC 3.29%
ROICexc 3.33%
ROICexgc 10.5%
OM 6.39%
PM (TTM) 3.75%
GM 32.45%
FCFM 8.31%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score3
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.45
Debt/EBITDA 2.7
Cap/Depr 65.9%
Cap/Sales 4.82%
Interest Coverage 250
Cash Conversion 95.79%
Profit Quality 221.43%
Current Ratio 2.43
Quick Ratio 2.06
Altman-Z 2.94
F-Score3
WACC9.72%
ROIC/WACC0.34
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.66%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%25.71%
EPS Next Y47.1%
EPS Next 2Y31.71%
EPS Next 3Y16.78%
EPS Next 5Y19.42%
Revenue 1Y (TTM)11.81%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%21.3%
Revenue Next Year18.13%
Revenue Next 2Y12.77%
Revenue Next 3Y9.23%
Revenue Next 5Y9.3%
EBIT growth 1Y-18.82%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year206.59%
EBIT Next 3Y48.86%
EBIT Next 5Y35.49%
FCF growth 1Y42.8%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y43.49%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 5 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 3 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


What is the profitability of TRNS stock?

TRANSCAT INC (TRNS) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for TRNS stock?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 37.87 and the Price/Book (PB) ratio is 2.


What is the financial health of TRANSCAT INC (TRNS) stock?

The financial health rating of TRANSCAT INC (TRNS) is 5 / 10.